Alleviation of negative physical and psychological symptoms for cancer survivors Signs and Symptoms
Conditions
Interventions
Before commencing the sample recruitment, the principal investigator will use IBM SPSS Statistics to generate three sets of non-duplicating random numbers for the three study groups. These numbers wil
Sponsors
National University of Singapore
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 29/08/2024: 1. Adults of any gender aged 21 to 75 years 2. Having a confirmed diagnosis of any type of cancer stage 0 to III by their attending physician 3. Have completed all cancer and related treatments (such as chemotherapy, surgery, and radiotherapy, as prescribed by their attending physician), with the exception of hormonal therapy between 2 weeks to 2 years (Lengacher et al., 2016) Previous inclusion criteria: 1. Adults of any gender aged 21 to 65 years 2. Having a confirmed diagnosis of any type of cancer stage 0 to III by their attending physician 3. Have completed all cancer and related treatments (such as chemotherapy, surgery, and radiotherapy, as prescribed by their attending physician), with the exception of hormonal therapy between 2 weeks to 2 years (Lengacher et al., 2016)
Exclusion criteria
Exclusion criteria: 1. Having a diagnosis of severe mental disorders (e.g., schizophrenia, mood disorders, bipolar disorder, and substance-related disorders) 2. Having a severe medical condition requiring hospitalisation 3. Is pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psychological well-being measured with the 18-item Psychological Well-being scale before the beginning of the first intervention session, and at the end of sessions 4 and 8 (middle- and end-point of the intervention) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Objective stress measured by peripheral skin temperature using a stress thermometer, and heart rate and SpO2 variability measured using Honour Band 5. Measured before and after each of the eight intervention sessions. 2. Subjective stress, depression, and anxiety measured with the 21-item Depression Anxiety and Stress scale (DASS-21) before the beginning of the first intervention session, and at the end of sessions 4 and 8 (middle- and end-point of the intervention) 3. Perceived relaxation assessed by the perceived relaxation scale before and after each of the eight intervention sessions 4. Mindfulness measured with the 15-item Mindful Attention Awareness Scale (MAAS) before the beginning of the first intervention session, and at the end of sessions 4 and 8 (middle- and end-point of the intervention) 5. Resilience assessed by the 10-item Connor-Davidson Resilience Scale before the beginning of the first intervention session, and at the end of sessions 4 and 8 (middle- and end-point of the intervention) 6. Participants’ perceptions toward the two mindfulness interventions will be captured via focus-group interviews conducted after the last of the eight intervention sessions | — |
Countries
Singapore
Outcome results
None listed